Wilmot Oncologist Named Deputy Chair of National Cancer Research Group
October 06, 2005
Richard I. Fisher, M.D.
The director of the James P. Wilmot Cancer Center was recently named deputy chair of the Southwest Oncology Group (SWOG), one of the largest cancer clinical trials cooperative groups in the United States. Richard I. Fisher, M.D., will also lead the group’s scientific advisory board, which oversees clinical cancer research around the country.
“I consider it a privilege to serve as dputy chair and to help guide the Scientific Advisory Board,” Fisher said. “Southwest Oncology Group has made great strides in the fight against cancer and we are getting closer every day to solving and treating the many forms of cancer.”
Fisher has been active in the Southwest Oncology Group, which includes a network of more than 5,000 clinician-scientists at nearly 650 institutions, for 20 years. He has been chair of the Lymphoma Committee since 1988 and co-chair of the Tumor Biology Lymphoma Subcommittee since 1993. In addition, he serves as a member of the SWOG Board of Governors and the Correlative Science Committee.
Fisher was named director of the University of Rochester Medical Center’s Wilmot Cancer Center and director of Cancer Services for Strong Health in 2001. He is also director of the Hematology/Oncology Division in the Department of Medicine and the Samuel E. Durand Professor of Medicine. He was previously director of the Cardinal Bernardin Cancer Center at Loyola University.
A graduate of Harvard College and Harvard Medical School, he completed an internship and residency at Massachusetts General Hospital. He held an oncology fellowship and worked as a Senior Investigator at the National Cancer Institute from 1972 to 1984.
SWOG researchers enroll nearly 7,200 patients into clinical trials each year and have about 120 clinical trials underway at any given time.
# # #